Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
Rhea-AI Summary
Strata Critical Medical (Nasdaq: SRTA) plans to release its second quarter 2026 financial results for the period ended July 31, 2026 on Tuesday, August 4, 2026, before the U.S. market opens. Management will host an earnings conference call and audio-only webcast at 8:00 a.m. Eastern Time, followed by a Q&A session. According to Strata, investors can access the live call by registering to receive dial-in details and a unique PIN, or listen via webcast in the Investors section of the company’s website, where a replay will remain available for one year.
Positive
- None.
Negative
- None.
News Market Reaction – SRTA
In the Jul 22 session, SRTA declined 1.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 24 | Acquisition announcement | Positive | -1.1% | Acquired HLT-NRP for $21.5 million to expand the transplant clinical platform. |
| Jun 02 | Acquisition announcement | Positive | +2.3% | Completed Louisville Perfusion Services acquisition with performance-based consideration. |
| May 07 | Warrant expiration | Neutral | +4.3% | Public and private placement warrants expired under their original terms. |
| May 06 | Earnings report | Positive | +10.6% | Reported Q1 results and reiterated 2026 revenue, EBITDA, and free cash flow guidance. |
| Apr 30 | Acquisition announcement | Positive | +1.2% | Completed Ohio Valley Perfusion Associates acquisition for approximately $1 million. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical reactions were mostly aligned with positive corporate announcements, with one negative acquisition reaction and one positive move following warrant expiration.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the second quarter ended July 31, 2026 on Tuesday, August 4, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants.
To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here. A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit www.srta.com.
Contacts
Mathew Schneider
investors@srta.com
